Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy

Journal of the National Cancer Institute

Volumn 92, Issue 23, 2000, Pages 1881-1888

  Correa, Pelayo ^a   Fontham, Elizabeth T H ^a   Bravo, Juan C ^c   Bravo, Luis E ^c   Ruiz, Bernardo ^a   Zarama, Guillermo ^d   Realpe, J Luis ^d   Malcom, Gray T ^a   Li, Daner ^a   Johnson, William D ^b   Mera, Robertino ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSIDAD DEL VALLE   (Colombia)

^d Hospital Universitario Departamental   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ASCORBIC ACID; BETA CAROTENE; BISMUTH SALICYLATE; CARBON 13; CLARITHROMYCIN; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; MUCIN; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; TRACE ELEMENT; UREA;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DYSPLASIA; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RURAL POPULATION; SIDE EFFECT; STOMACH BIOPSY; STOMACH CARCINOMA;

EID: 0034614094     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.23.1881     Document Type: Article

References (37)

1. IARC monographs on the evaluation of carcinogenic risks to humans: Schistosomes, liver flukes and Helicobacter pylori
2. Cancer and infection: Estimates of the attributable fraction in 1990
3. Pylori and gastric cancer: The significance of the problem
4. Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer
5. Dietary determinants of gastric cancer in south Louisiana inhabitants
6. Lessons from ongoing intervention studies
7. Gastric cancer in Colombia. III. Natural history of precursor lesions
8. Human gastric carcinogenesis: A multistep and multifactorial process-first american cancer society award lecture on cancer epidemiology and prevention
9. Gastric precancerous process in a high risk population: Cohort follow-up
10. Gastric precancerous process in a high risk population: Cross-sectional studies
11. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma
12. Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice
13. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment
14. 13C-urea breath test
15. 13C urea breath test
16. Diamine methods for differentiating mucosubstances histochemically
17. Modified Steiner for the demonstration of spirochetes
18. Classification and grading of gastritis
19. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia
20. Chronic gastritis: A clinico-pathological classification
21. Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication
22. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
23. Applied logistic regression
24. Estimates of the worldwide incidence of eighteen major cancers in 1985
25. Trends in cancer incidence and mortality
26. Age distribution of Helicobacter pylori seroprevalence among young children in the United States/Mexico border community: Evidence for transitory infection
27. Effects of the combination of beta carotene and vitamin A on lung cancer incidence and cardiovascular disease
28. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population
29. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations
30. Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans
31. Helicobacter pylori and gastric carcinogenesis
32. The risk of stomach cancer in patients with gastric and duodenal ulcer disease
33. Precancerous gastric lesions in a population at high risk of stomach cancer
34. Gastric dysplasia: The Padova international classification
35. Helicobacter pylori infection in the Colombian Andes: A population-based study of transmission pathways
36. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk